Laparoscopic devices Market Set for Steady Expansion by 2032, Driven by Innovation and Growing Surgical Volumes | DelveInsight

The global laparoscopic devices market was valued at USD 11.35 billion in 2023 and is projected to grow at a CAGR of 9.14%, reaching approximately USD 19.13 billion by 2030. This growth is fueled by the rising incidence of gastrointestinal and colorectal cancers, which is increasing the need for effective surgical solutions. Additionally, the widespread shift toward minimally invasive procedures-thanks to benefits like reduced hospital stays and lower healthcare expenses-is boosting demand. Technological advancements in laparoscopic equipment, including improved imaging, precision tools, and robotic-assisted systems, are further propelling market expansion through 2030.

DelveInsight's Laparoscopic devices Market Insights report provides the current and forecast market analysis, individual leading Laparoscopic devices companies' market shares, challenges, Laparoscopic devices market drivers, barriers, and trends, and key Laparoscopic devices companies in the market.

Request for a sample report @ https://www.delveinsight.com/report-store/laparoscopic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr

Key Takeaways from the Laparoscopic devices Market Report
The Laparoscopic devices market is projected to grow at a moderate CAGR from 2025 to 2032.
As per DelveInsight estimates, North America is anticipated to dominate the global Laparoscopic devices market during the forecast period.
Some of the key market players operating in the laparoscopic devices market include Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., and others.
In June 2023, Canadian surgical instrument manufacturer **Xpan** secured **510(k) clearance** from the **U.S. FDA** for its **Universal Trocars System**, engineered to reduce tissue trauma and improve surgical access in laparoscopic procedures.
In March 2023, **Peters Surgical** completed the acquisition of **Vectac**, a France-based medical device company, as part of its strategic growth efforts. This move expanded Peters Surgical's laparoscopic product line-adding trocars, scissors, and endoscopic forceps-aimed at meeting the needs of **gynecology, urology, and visceral surgery**.
In January 2022, **Shanghai MicroPort MedBot Co., Ltd.** announced that its **Toumai® Laparoscopic Surgical Robot** received **marketing approval** from **China's National Medical Products Administration (NMPA)**, marking a significant advancement in robotic-assisted laparoscopic surgery.

To read more about the latest highlights related to the Laparoscopic devices market, get a snapshot of the key highlights entailed in the Global Laparoscopic devices Market Report https://www.delveinsight.com/report-store/laparoscopic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Laparoscopic devices Overview

Laparoscopic devices are specialized surgical tools used in minimally invasive procedures, where operations are performed through small incisions using a laparoscope-a thin, lighted tube equipped with a camera. These devices have revolutionized surgery by enabling high-precision procedures with reduced trauma, shorter hospital stays, faster recovery, and minimal scarring compared to traditional open surgeries.


Laparoscopic devices Market Insights

North America is projected to dominate the laparoscopic devices market in 2023, primarily due to the rising incidence of cancers such as gallbladder, colorectal, and uterine cancers. According to GLOBOCAN (2024), around 279,000 new cases of these cancers were reported in the region in 2022.

The growing preference for minimally invasive surgeries-offering reduced recovery time, less postoperative pain, and fewer complications-is further driving market growth. Laparoscopic procedures like cholecystectomy for gallbladder cancer, colectomy for colorectal cancer, and hysterectomy for uterine cancer are widely adopted due to their precision and patient-friendly outcomes.

Additionally, the presence of key industry players and their strategic initiatives are boosting the regional market. These factors together position North America as the leading market for laparoscopic devices during the forecast period.

To know more about why North America is leading the market growth in the Laparoscopic devices market, get a snapshot of the Laparoscopic devices Market Outlook https://www.delveinsight.com/sample-request/laparoscopic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Laparoscopic devices Market Dynamics

According to GLOBOCAN (2024), colorectal cancer had approximately 1.93 million new global cases in 2022, projected to rise to 3.29 million by 2045. Similarly, the International Agency for Research on Cancer reported 4.8 million global cases of gastrointestinal cancer. As these cancer rates increase, the demand for less invasive, effective surgical solutions like laparoscopy is growing rapidly.

Laparoscopic procedures-such as colectomies for colorectal cancer and gastrectomies for stomach cancer-offer significant benefits, including reduced surgical trauma, faster recovery, and improved post-operative outcomes, making them the preferred option for many gastrointestinal surgeries. This rising adoption is driving the global laparoscopic devices market.

To meet growing demand, companies are expanding production and gaining regulatory approvals. For instance, Genesis MedTech's ArtiSentialTM received market approval in China in July 2023, further boosting industry growth.

While the market outlook remains positive, challenges like limited depth perception in laparoscopic procedures and strict regulatory requirements may pose hurdles. Nonetheless, the laparoscopic device market is expected to expand steadily through the forecast period.


Laparoscopic devices Market Drivers:

Increase in incidence of cancer such as gastrointestinal and colorectal cancer
Growing adoption of minimally invasive surgeries across the globe
Growing advancement in laparoscopic technology

Get a sneak peek at the Laparoscopic devices market dynamics @ https://www.delveinsight.com/report-store/laparoscopic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Coverage: Global
Study Period: 2022 to 2032
Key Laparoscopic devices Companies: Medtronic, Stryker, Shenzen Mindray Bio Medical Electronics Co., Ltd., Johnson & Johnson, Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical., CONMED Corporation., Becton, Dickinson and Company, Smith & Nephew, Microline Surgical., Optomic., Palliare Ltd, Sejong Medical Co., Ltd., BIOSISHEALING, Richard Wolf GmbH., Bolder Surgical (Hologic Inc.), RUDOLF Medical GmbH + Co. KG., EMOS Technology GmbH, Teleflex Incorporated., and others.

Which MedTech key players in the Laparoscopic devices market are set to emerge as the trendsetter, explore @ Laparoscopic devices Companies @ https://www.delveinsight.com/sample-request/laparoscopic-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr


Table of Contents
1. Laparoscopic devices Market Report Introduction
2. Laparoscopic devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Laparoscopic devices Market Key Factors Analysis
6. Laparoscopic devices Market Porter's Five Forces Analysis
7. Laparoscopic devices Market Layout
8. Laparoscopic devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us

Contact Info:
Kritika Rehani
Assistant Manager, Marketing & Branding
krehani@delveinsight.com
info@delveinsight.com
+14699457679

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

This release was published on openPR.